Skandinaviska Enskilda Banken (SEB)’s Harmony Biosciences HRMY Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,400	Closed	-$614K	–	412
2025 Q4	$614K	Hold	16,400	–	–	﹤0.01%	646
2025 Q3	$451K	Hold	16,400	–	–	﹤0.01%	669
2025 Q2	$518K	Hold	16,400	–	–	﹤0.01%	700
2025 Q1	$544K	Buy	+16,400	New	+$588K	﹤0.01%	679
2024 Q4	–	Sell	-12,700	Closed	-$508K	–	852
2024 Q3	$508K	Buy	+12,700	New	+$446K	﹤0.01%	714
2023 Q4	–	Sell	-25,947	Closed	-$850K	–	943
2023 Q3	$850K	Hold	25,947	–	–	0.01%	701
2023 Q2	$913K	Hold	25,947	–	–	0.01%	714
2023 Q1	$847K	Sell	25,947 -1,234	-5%	-$56.2K	0.01%	708
2022 Q4	$1.5M	Sell	27,181 -1,574	-5%	-$86.5K	0.01%	596
2022 Q3	$1.27M	Hold	28,755	–	–	0.01%	629
2022 Q2	$1.4M	Hold	28,755	–	–	0.01%	648
2022 Q1	$1.4M	Buy	28,755 +9,954	+53%	+$406K	0.01%	691
2021 Q4	$814K	Buy	+18,801	New	+$749K	﹤0.01%	800

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s HRMY Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 16,400 shares — an estimated $614K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in HRMY in Q4 2021 and held it in 13 quarters. The position peaked at $1.5M in Q4 2022. 311 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

Skandinaviska Enskilda Banken (SEB) reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 16,400 Harmony Biosciences shares in Q1 2026, an estimated $614K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Harmony Biosciences in Q4 2021 and held it in 13 quarters.
Skandinaviska Enskilda Banken (SEB)'s Harmony Biosciences position peaked at $1.5M in Q4 2022.
311 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.